Trial Details
COMPLETEDBasic Information
| Clinical ID | c1695 |
|---|---|
| Identifier | NCT01045018 |
| Trial Title | A BE Study Comparing Mesalamine 400 mg to ASACOL 400 mg in Patients With Mild To Moderately Active Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Mild to Moderate Ulcerative Colitis |
| Interventions | DRUG: Placebo|DRUG: Mesalamine|DRUG: Mesalamine |
Participant Information
| Sponsor | EMET Pharmaceuticals, LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-01-08 |
|---|---|
| Primary Completion Date | 2025-06-09 |
| Completion Date | 2025-08-09 |